Svenja Wiechmann
Principal Investigator at Phialogics - The immune tolerance company- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Phialogics - The immune tolerance company
-
Germany
-
Biotechnology Research
-
1 - 100 Employee
-
Principal Investigator
-
Jan 2023 - Present
Frankfurt Rhine-Main Metropolitan Area, Germany
-
-
-
Ionis Pharmaceuticals, Inc.
-
United States
-
Biotechnology Research
-
500 - 600 Employee
-
Senior Scientist
-
Jan 2021 - Oct 2022
Carlsbad, California, United States
-
-
Postdoctoral fellow
-
Oct 2019 - Jan 2021
Carlsbad, California, United States Development of novel methods to identify ligands for tissue-specific delivery of therapeutic antisense oligonucleotide (ASO) drugs.
-
-
-
-
Postdoctoral fellow
-
Sep 2018 - Jun 2019
Frankfurt am Main, Germany Antibody and cytokine engineering. Phage display using a synthetic Fab library to select against cytokines. Cloning of Fab-fragments as full length IgGs. Production and purification of IgG and Fc-chimera proteins in mammalian cells.
-
-
-
Goethe University
-
Germany
-
Higher Education
-
700 & Above Employee
-
PhD student at Institute of Biochemistry II
-
Sep 2013 - Sep 2018
Frankfurt am Main, Germany Engineering of intracellular affinity reagents based on ubiquitin and ubiquitin-like proteins targeting oncogenic Ras GTPases, proteasomal receptors and SUMO-conjugating enzymes.
-
-
Education
-
2013 - 2018
Johann Wolfgang Goethe-Universität Frankfurt am Main
Dr. phil. nat., Biochemistry -
2007 - 2013
Technische Universität Darmstadt
Diploma (Master of Science), Biology/Biochemistry -
2010 - 2011
University of Technology Sydney
Studies aboad, Biochemistry and Molecular Biology
Community
